BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

288 related articles for article (PubMed ID: 28273350)

  • 1. Sexual dysfunction and its determinants among women infected with HIV.
    Agaba PA; Meloni ST; Sule HM; Agaba EI; Idoko JA; Kanki PJ
    Int J Gynaecol Obstet; 2017 Jun; 137(3):301-308. PubMed ID: 28273350
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence and risk factors for female sexual dysfunction in women attending a medical clinic in south India.
    Singh JC; Tharyan P; Kekre NS; Singh G; Gopalakrishnan G
    J Postgrad Med; 2009; 55(2):113-20. PubMed ID: 19550056
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence, risk factors, and predictors of female sexual dysfunction in a primary care setting: a survey finding.
    Ishak IH; Low WY; Othman S
    J Sex Med; 2010 Sep; 7(9):3080-7. PubMed ID: 20584130
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The prevalence and risk factors of female sexual dysfunction in young korean women: an internet-based survey.
    Song SH; Jeon H; Kim SW; Paick JS; Son H
    J Sex Med; 2008 Jul; 5(7):1694-701. PubMed ID: 18422495
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Body image is a major determinant of sexual dysfunction in stable HIV-infected women.
    Luzi K; Guaraldi G; Murri R; De Paola M; Orlando G; Squillace N; Esposito R; Rochira V; Zirilli L; Martinez E
    Antivir Ther; 2009; 14(1):85-92. PubMed ID: 19320240
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence of sexual dysfunction in infertile versus fertile couples.
    Gabr AA; Omran EF; Abdallah AA; Kotb MM; Farid EZ; Dieb AS; Belal DS
    Eur J Obstet Gynecol Reprod Biol; 2017 Oct; 217():38-43. PubMed ID: 28843867
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence of sexual dysfunction and impact of contraception in female German medical students.
    Wallwiener CW; Wallwiener LM; Seeger H; Mück AO; Bitzer J; Wallwiener M
    J Sex Med; 2010 Jun; 7(6):2139-2148. PubMed ID: 20487241
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessment of sexual dysfunction and determination of its risk factors in the Republic of Korea.
    Choi H; Kim JH; Park JY; Shim JS; Lee JG; Yoon HY; Bae JH
    Int J Gynaecol Obstet; 2014 Apr; 125(1):60-4. PubMed ID: 24462326
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Female sexual dysfunction among married women in the Gaza Strip: an internet-based survey.
    Maasoumi R; Elsous A; Hussein H; Taghizadeh Z; Baloushah S
    Ann Saudi Med; 2019; 39(5):319-327. PubMed ID: 31580717
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence and differences between type 1 and type 2 diabetes mellitus regarding female sexual dysfunction: a cross-sectional Egyptian study.
    Ahmed MR; Shaaban MM; Sedik WF; Mohamed TY
    J Psychosom Obstet Gynaecol; 2018 Sep; 39(3):176-181. PubMed ID: 28436753
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence of female sexual dysfunction in urban chinese women based on cutoff scores of the Chinese version of the female sexual function index: a preliminary study.
    Ma J; Pan L; Lei Y; Zhang A; Kan Y
    J Sex Med; 2014 Apr; 11(4):909-919. PubMed ID: 24754329
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The prevalence of sexual dysfunction and potential risk factors that may impair sexual function in Malaysian women.
    Sidi H; Puteh SE; Abdullah N; Midin M
    J Sex Med; 2007 Mar; 4(2):311-21. PubMed ID: 17040486
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Female sexual dysfunction in multiple sclerosis: Results of a survey among Dutch urologists and patients.
    Scheepe JR; Alamyar M; Pastoor H; Hintzen RQ; Blok BF
    Neurourol Urodyn; 2017 Jan; 36(1):116-120. PubMed ID: 26493281
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence of female sexual dysfunction in allied health workers: a cross-sectional pilot study in a tertiary hospital in Singapore.
    Safdar F; Eng CLJ; Wai KL; Tey WS; Ang SB
    BMC Womens Health; 2019 Nov; 19(1):137. PubMed ID: 31727041
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development and validation of a 6-item version of the female sexual function index (FSFI) as a diagnostic tool for female sexual dysfunction.
    Isidori AM; Pozza C; Esposito K; Giugliano D; Morano S; Vignozzi L; Corona G; Lenzi A; Jannini EA
    J Sex Med; 2010 Mar; 7(3):1139-46. PubMed ID: 19968774
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recent and lifelong sexual dysfunction in a female UK population sample: prevalence and risk factors.
    Burri A; Spector T
    J Sex Med; 2011 Sep; 8(9):2420-30. PubMed ID: 21676186
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence of sexual dysfunction among females in a university community in Enugu, Nigeria.
    Nwagha UI; Oguanuo TC; Ekwuazi K; Olubobokun TO; Nwagha TU; Onyebuchi AK; Ezeonu PO; Nwadike K
    Niger J Clin Pract; 2014; 17(6):791-6. PubMed ID: 25385921
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sexuality and psychopathological aspects in premenopausal women with metabolic syndrome.
    Alvisi S; Baldassarre M; Lambertini M; Martelli V; Berra M; Moscatiello S; Marchesini G; Venturoli S; Meriggiola MC
    J Sex Med; 2014 Aug; 11(8):2020-8. PubMed ID: 24848980
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A 10-year interval study to compare the prevalence and risk factors of female sexual dysfunction in Korea: the Korean internet sexuality survey (KISS) 2014.
    Shin H; Min B; Park J; Son H
    Int J Impot Res; 2017 Mar; 29(2):49-53. PubMed ID: 27928152
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The prevalence of sexual dysfunction and associated risk factors in women with chronic pelvic pain: a cross-sectional study.
    Verit FF; Verit A; Yeni E
    Arch Gynecol Obstet; 2006 Aug; 274(5):297-302. PubMed ID: 16705463
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.